17 Apr 2012 07:00
FOR IMMEDIATE RELEASE | 17 April 2012 |
ImmuPharma plc
Annual Report and Accounts
Notice of Annual General Meeting: 23 May 2012
In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM: IMM) (the "Company") the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2011 has been posted to shareholders.
The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.
The Company's Annual General Meeting will be held on 23 May 2012 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London SW1H 0BL.
- Ends -
For further information please contact:
ImmuPharma plc | + 44 (0) 20 7152 4080 |
Dimitri Dimitriou, Chief Executive Officer | |
Lisa Baderoon, Head of Investor Relations | + 44 (0) 7721 413496 |
Buchanan | + 44 (0) 20 7466 5000 |
Mark Court | |
Jessica Fontaine | |
Panmure, Gordon & Co., NOMAD & Broker | +44 (0) 20 7459 3600 |
Andrew Burnett | |
Fred Walsh | |
Espirito Santo Investment Bank | +44 (0) 20 7456 9191 |
James Bromhead | |
Richard Crawley |
Immupharma (IMM)